Featured
-
-
Article
| Open AccessOpen-label placebo treatment does not enhance cognitive abilities in healthy volunteers
- Helena Hartmann
- , Katarina Forkmann
- & Ulrike Bingel
-
Article
| Open AccessEffects of lidocaine incorporation (without epinephrine) on pain and 2-week complications of botulinum toxin: a double-blind randomized placebo-controlled clinical trial
- Farzin Sarkarat
- , Diba Bagheri
- & Vahid Rakhshan
-
Article
| Open AccessThe impact of pharmaceutical form and simulated side effects in an open-label-placebo RCT for improving psychological distress in highly stressed students
- Alexander Winkler
- , Alannah Hahn
- & Christiane Hermann
-
Article
| Open AccessImaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms
- Sarah Buergler
- , Dilan Sezer
- & Jens Gaab
-
Article
| Open AccessAttention neuroenhancement through tDCS or neurofeedback: a randomized, single-blind, controlled trial
- Gabriel Gaudencio Rêgo
- , Óscar F. Gonçalves
- & Paulo Sérgio Boggio
-
Article
| Open AccessThe effectiveness of dry needling in patients with chronic low back pain: a prospective, randomized, single-blinded study
- Joanna Rajfur
- , Katarzyna Rajfur
- & Jakub Taradaj
-
Article
| Open AccessEffects of open-label placebos in clinical trials: a systematic review and meta-analysis
- Melina von Wernsdorff
- , Martin Loef
- & Stefan Schmidt
-
Article
| Open AccessPositive expectations predict improved mental-health outcomes linked to psychedelic microdosing
- L. S. Kaertner
- , M. B. Steinborn
- & R. L. Carhart-Harris
-
Article
| Open AccessOpen-Label Placebo Treatment for Cancer-Related Fatigue: A Randomized-Controlled Clinical Trial
- Teri W. Hoenemeyer
- , Ted J. Kaptchuk
- & Kevin R. Fontaine
-
Article
| Open AccessPlacebo Response is Driven by UCS Revaluation: Evidence, Neurophysiological Consequences and a Quantitative Model
- Luca Puviani
- & Sidita Rama